In 2017, MAPS-sponsored ibogaine researcher Thomas Kingsley Brown took it beyond mice and rats — he conducted his observational study on patients at the La Misión ibogaine clinic in Mexico. And Franciotti was one of his test subjects.
That study concluded that ibogaine has a “substantiated treatment effect in opioid detoxification” and that it “provided distinctive benefit for individuals with histories of previously unsuccessful treatment.”
Originally appearing here (Archived)